Phathom Pharmaceuticals, Inc.
PHAT · XNASCIK 1783183fmd_0C99VKKHFDH78J02C17GPXJAGHManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2018 to Sep 30, 2026, 35 periods
AI-written
A model wrote this from the company's own SEC filings and our standardized facts. It is not reported fact, not an analyst's estimate, not a rating and not investment advice. Every claim shows what it rests on.
Loading